Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Interferon Sciences updates on status of Alferon N Injection clinical trials program

Aug. 13, 1998

DNA vaccine provides complete protection against rabies

Aug. 12, 1998

Liposomal FK-506 is effective as an immunosuppressant and antiinflammatory agent

Aug. 12, 1998

OspA vaccine prevents Lyme disease and asymptomatic infection

Aug. 11, 1998

FluMist protects against influenza infection in second year of two-year study

Aug. 10, 1998

Single-antigen pertussis vaccine approved by FDA

Aug. 10, 1998

Potassium channel-blocking immunosuppressants from Merck & Co.

July 29, 1998

Novavax extends option agreement with Cantab

July 29, 1998

Scientists report success in achieving tolerance in transplantation models

July 22, 1998

Lisofylline development timetable readjusted, marketing agreements revised

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...